Nintendo Co. increased its production target for Switch to 25 million units this fiscal as the ongoing pandemic keeps boosting demand while component shortages ease.
The Kyoto-based company, which previously hiked orders to 22 million units by March next year, asked assembly partners to add the extra million units.
The assembly partners intend to maximize production capacity through December.
Nintendo forecasts its Switch sales at 19 million units for the current fiscal year.
Plans could still change if demand begins to taper in the coming months, but production partners expect to surpass the 22 million units previously instructed to assemble.
Nintendo's assembly partners, who initially prioritized handset contracts from major smartphone manufacturers, found themselves with more capacity as orders plummeted due to the economic downturn and the roiling US-China conflict.
The company has been boosting Switch production since the start of this year, even before its hit game Animal Crossing: New Horizons became the breakout success of the novel coronavirus era.
Nintendo's hit game Animal Crossing fueled global Switch sales, resulting in a fivefold leap in operating profit to US$1.4 billion in the quarter ended in June.
Animal Crossing: New Horizons, which sold nearly 12 million copies in its first 11 days in March, sold another 10.6 million units in the second quarter.
It is close to becoming the best-selling Switch title ever.
Nintendo noted that over half of new Switch owners over the last quarter played Animal Crossing first.


Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Google to Move All Pixel Production Out of China by 2027
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
OpenAI Tightens AI Safety Monitoring After Security Incidents
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
REPAY Stock Rises After Visa Platform Connect Collaboration
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 



